Temazepam
1Provenance card
the boundary, as counts
Sources
4312 with DOI
17 strong · 20 moderate · 6 weak
Compilations
12026-05-09T13:16:05.961Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
34last ruled 2026-06-04
1 awaiting a ruling
Issued documents
42026-10-19T20:34:07.457Z
notice · info card · emergency
Searches
200 with no results
queries and counts on the build
Claims checked
1548 supported
8 supported · 146 not
Correspondence
0received
consent field ships in Phase 4
Edges
417
derivations recorded for this entity
Complete over 43 sources, 1 compilation, and 34 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/temazepam/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued info_card
- 2026-10-02srcReview of Safety and Efficacy of Sleep Medicines in Older Adults
- 2026-10-02srcTemazepam 10mg does not affect breathing and gas exchange in patients with severe normocapnic COPD
- 2026-10-02srcPharmacological agents for improving sleep quality at high altitude: a systematic review and meta-analysis of randomized controlled trials
- 2026-10-02srcEffect of hypnotic drugs on body balance and standing steadiness
- 2026-10-02srcConsensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
- 2026-10-02srcEffects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial
- 2026-10-02srcAdverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication--A Systematic Review with Meta-Analyses.
- 2026-10-02srcThe European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
- 2026-10-02srcSedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
- 2026-10-02srcClinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
- 2026-10-02srcRisks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use
- 2026-10-02srcClinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
- 2026-10-02srcA comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience
- 2026-10-02srcDrug related deaths in the Strathclyde region of Scotland, 1995-1998
- 2026-10-02srcA double-blind comparison of the effects of temazepam and triazolam on residual, daytime performance in elderly insomniacs
- 2026-10-02srcComparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia
- 2026-10-02srcZolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study
- 2026-10-02srcAdrenergic modulation of preoperative anxiety: a comparison of temazepam, clonidine, and timolol
- 2026-10-02srcA double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia
- 2026-10-02srcMelatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial
- 2026-10-02srcEffects of temazepam premedication on cognitive recovery following alfentanil-propofol anaesthesia
- 2026-10-02srcEffects of end-stage renal disease and aluminum hydroxide on temazepam kinetics
- 2026-10-02srcQuazepam and temazepam: effects of short- and intermediate-term use and withdrawal
- 2026-10-02srcPharmacokinetics of temazepam after day-time and night-time oral administration
- 2026-10-02srcEfficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months
- 2026-10-02srcTemazepam or Melatonin Versus Placebo for the Treatment of Insomnia in Advanced Cancer: A Three-Arm, Double-Blind, Phase III, Multicenter, Randomized Clinical Trial
- 2026-10-02srcPharmacokinetics and metabolism of temazepam in man and several animal species
- 2026-10-02srcBioavailability of temazepam in soft gelatin capsules
- 2026-10-02srcTemazepam — PubChem Compound
- 2026-10-02srcHuman pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules
- 2026-10-02srcTemazepam as premedication in elderly patients
- 2026-10-02srcSleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects
- 2026-10-02srcBenzodiazepine withdrawal syndrome: a literature review and evaluation
- 2026-10-02srcHypnotic action of benzodiazepines: a possible mechanism
- 2026-10-02srcAnxiolytic drugs: dependence, addiction and abuse
- 2026-10-02srcLimb ischaemia after intra-arterial injection of Temazepam gel: histology of nine cases
- 2026-10-02srcBioavailability of temazepam: comparison of four 7.5-MG capsules with a single 30-MG capsule
- 2026-10-02srcIntra-arterial injection of temazepam in drug abusers
- 2026-10-02srcSedative-hypnotic drugs and the risk of hip fracture
- 2026-10-02srcTemazepam physical/chemical properties (CAS 846-50-4)
- 2026-10-02srcTemazepam - Legal status by jurisdiction
- 2026-10-02srcTemazepam - StatPearls
- 2026-10-02srcTemazepam capsules: what was the problem?
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-07-03proposaldependence · taper
- 2026-06-04proposal31 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-09revisionRevision 1
- 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
- 2026-05-09rungeneration run
The same entries, as forms: six forms.